futuristic experience with the Oakley Icon Outpost—a cutting-edge showcase of the brand’s innovation, legacy, and bold vision for the future of football. At the center of this narrative is Max ...

Ipsen has expanded its oncology pipeline by licensing rights to an antibody-drug conjugate (ADC) for solid tumours from Sutro Biopharma, its first drug in the category. The deal, which has a top ...